For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of this treatment and Attruby represents a true breakthrough . These novel therapies preserve the transthyretin protein, slowing its harmful build-up and lessening the impact of the condi